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SUMMARY
Yellow fever (YF) is an acute viral infectious disease transmitted by mosquitoes which occurs in two distinct epidemiological 
cycles: sylvatic and urban. In the sylvatic cycle, the virus is maintained by monkey’s infection and transovarian transmission in vectors. 
Surveillance of non-human primates is required for the detection of viral circulation during epizootics, and for the identification of 
unaffected or transition areas. An ELISA (enzyme-linked immunosorbent assay) was standardized for estimation of the prevalence of 
IgG antibodies against yellow fever virus in monkey sera (Alouatta caraya) from the reservoir area of Porto Primavera Hydroelectric 
Plant, in the state of São Paulo, Brazil. A total of 570 monkey sera samples were tested and none was reactive to antibodies against 
yellow fever virus. The results corroborate the epidemiology of yellow fever in the area. Even though it is considered a transition 
area, there were no reports to date of epizootics or yellow fever outbreaks in humans. Also, entomological investigations did not 
detect the presence of vectors of this arbovirus infection. ELISA proved to be fast, sensitive, an adequate assay, and an instrument 
for active search in the epidemiological surveillance of yellow fever allowing the implementation of prevention actions, even before 
the occurrence of epizootics.
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INTRODUCTION
Yellow fever (YF) is an infectious viral disease that remains endemic 
or enzootic in rainforests of both South America and sub-Saharan Africa, 
periodically causing isolated outbreaks or epidemics of major public 
health impact. YF virus is the prototype of the genus Flavivirus, family 
Flaviviridae, a single, positive-stranded, enveloped RNA virus. It is 
transmitted to humans through bites of haematophagous insects of the 
family Culicidae, principally of the genera Aedes and Haemagogus17,23. 
There are two main cycles of transmission of yellow fever: urban 
and sylvatic. They have different vectors, vertebrate host and areas of 
occurrence17,18.
In the urban yellow fever, the domestic mosquito Aedes aegypti 
carries the infection from person to person. Infected humans experiencing 
the viremic phase of the illness act as amplifiers. After the virus penetrates 
an urban environment, those infected will develop viremia and can 
manifest the disease and be a source of infection for new mosquitoes25. 
The sylvatic yellow fever is maintained by virus circulation between 
monkeys and diurnally active mosquitoes that breed in tree holes in 
the forest canopy (Haemagogus spp. in South America and Aedes 
spp. in Africa). In Brazil, the YF virus main vector is the Haemagogus 
janthinomys, but other species of this genus and also of the genus Sabethes 
play a role in the maintenance cycle, acting as secondary vectors.
Cases of sylvatic yellow fever in humans are incidental and they 
occur when a non-vaccinated individual penetrates into areas where 
the virus is circulating and is bitten by mosquitoes that had acquired 
infection from monkeys24.
Many species of non-human primates are hosts of the sylvatic 
transmission cycle. Species most commonly involved in virus transmission 
belong to the genera Cebus, Alouatta and Callithrix 2, 8, 9. While in Africa 
the majority of simian species has greater resistance to yellow fever virus 
infection, and rarely develops disease, in the Americas some neotropical 
species of monkeys are more susceptible to develop lethal infections28.
The principal exception is genera Cebus (tufted capuchin monkey) 
which is more resistant to yellow fever virus infection. Infected monkeys 
do not die but develop antibodies against the virus28. 
Monkey susceptibility to the yellow fever virus in the Americas 
has been considered a major indicator for enzootic disease outbreaks 
in forest areas28.
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In recent years, sylvatic cases of yellow fever in humans in Brazil 
were often preceded by epizootics in animals. Epizootics are considered 
a sentinel event for potential circulation of sylvatic yellow fever virus 
among monkeys. 
In Brazil, there have been repeated epizootics since 2001, and the first 
cases reported were in the southern state of Rio Grande do Sul. Between 
2003 and 2004, other epizootics were reported in several Brazilian states 
within areas outside those identified as endemic. A major southward 
extension of the epizootic was underway in 2007-2008, from southern 
Brazil into Paraguay and Argentina.
The objectives of the present study were: a) to standardize 
immunoenzymatic assay (ELISA) procedures for the detection of IgG 
antibodies in monkey sera samples, and b) to estimate the prevalence of 
IgG antibodies against yellow fever virus in serum samples of Alouatta 
caraya monkey species captured within surrounding areas of flooded 
lands after the construction of the Porto Primavera dam and hydroelectric 
plant, São Paulo State, Brazil.
MATERIALS AND METHODS
Study area: The study area is located at the right margin of a lake 
formed by the Rio Paraná dam in the reservoir area of Engenheiro Sérgio 
Motta Hydroelectric Plant (HEP), also known as Porto Primavera HEP, 
in the city of Presidente Epitácio, southwest region of the State of São 
Paulo, Brazil11.
Serum samples: Before inundation, monkeys of the Alouatta caraya 
species and other wild animals living in riparian forest areas adjacent to 
Porto Primavera HEP reservoir were rescued for an extensive research 
program with financial support from the São Paulo State Energy Company 
(CESP) with allowance of the Brazilian Institute of Environment and 
Renewable Natural Resources (IBAMA). Captures were carried out 
in May 2000 and between March and May 200111. Monkeys were 
preanesthetized with ketamine, following the Canadian Council on 
Animal Care ethical recommendations (1980-1984)5 and blood was 
drawn from their femoral veins using vacutainer tubes containing an 
anticoagulant agent (EDTA). A total of 570 serum samples were tested.
Serological tests 
Reagent preparation:
a) Immune ascitic fluid: Immune ascitic fluid (IAF) was prepared 
in young adult mice (Mus musculus) by inoculations of brain macerates 
from newborn mice infected with yellow fever (17D) vaccine virus. 
They were inoculated with 0.2 mL of this suspension diluted to 1:30 in 
phosphate-buffered saline (PBS) intraperitoneally, four times weekly. 
Five days following their last inoculation, the mice were inoculated 
with sarcoma 180/TG cells3. They developed voluminous ascites within 
a week indicating disease development and formation of antibodies 
against yellow fever virus12.
b) Yellow fever antigen: Yellow fever antigens were prepared at the 
Centre of Research in Virology, School of Medicine of Ribeirão Preto, 
University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil, 
following BARROS protocol1. In brief, newborn mice were inoculated 
with the yellow fever (17 D) vaccine virus intracerebrally and followed 
up for two weeks for the development of encephalitis, which occurred 
between day 4 and day 6 post-inoculation. 
The dying animals were sacrificed and frozen and stored in a freezer 
at -70º C. After thawing, their brains were suctioned, mixed and crushed 
using a mortar and pestle and diluted 1:20 (p/v) in RPMI-1640 cell culture 
media and stored at -70º C as viral seeds for subsequent use. The antigen 
was not inactivated.
c) Positive control: The positive control was provided by Laboratory 
of Flavivirus, Department of Virology, Oswaldo Cruz Foundation 
(FIOCRUZ), Rio de Janeiro, Brazil from Rhesus macaques.
d) Conjugate: Since there was not a specific conjugate for New World 
monkeys, at the time of the study, a commercially available conjugate 
produced in an Old World monkey (anti-Rhesus - Macaca mulatta, 
infra-ordem Catarrhini) was used in order to detect the IgG-class anti-
YF (17D) antibodies. Additionally, this reagent was used because of the 
evolutionary proximity among the monkeys’ species. 
The same conjugate was used in malaria studies and was able 
to detect IgG antibodies against sporozoite proteins (infective forms 
of Plasmodium species) in neotropical monkey blood samples7,11,27. 
Despite a possible loss in the test sensitivity, since it was used in a high 
concentration, the conjugate was competent to discriminate positive and 
negative sera, allowing its use in epidemiological studies.
Technique standardization 
A modified enzyme-linked immunosorbent assay (ELISA) was 
performed based on the protocol of the Centers for Disease Control and 
Prevention (CDC), in Atlanta, GA, U.S.A., as follows: 
Polystyrene microtiter plates (Maxisorp/Nunc) containing 96 wells 
were sensitized with 100 µL of IAF diluted in carbonate buffer solution 
(0.1 M and pH 9.6). Each well was sensitized in duplicate. The plates 
were incubated at 4º C overnight and then washed with a PBS-Tween 
20 solution five times. 
A blocking solution (250 µL) was added (PBS-Tween 20, 300 mL, 
and skim milk, 5.0 g) to each well and incubated for an hour at 37 ºC. 
No washings were carried out in this step. Seventy-five µL of antigen 
were diluted in the blocking solution and 100 µL were dispensed at each 
well. The plate was incubated again for an hour at 37 ºC and underwent 
a new cycle of washings with PBS-Tween 20. Serum samples (100 µL) 
for antibody detection were diluted in the blocking solution to 1:40 and 
dispensed followed by a new incubation and a cycle of five washings. 
Next, 100 µL of Rhesus monkey conjugate (Sigma A-2054) with 
peroxidase, diluted at 1:300 in the blocking solution, were added to each 
well. The plates were incubated for an hour at 37 ºC and then washed 
five times. 
In the last step, 100 µL of ABTS substrate (peroxidase substrate and 
peroxidase) were added. The plates were left to sit at room temperature 
in a place with no light for the development of color. Fifteen minutes 
later they were read in a Labsystems Multiskan (Multiskan) analyzer at 
a wavelength of 405 nm.
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To prevent false-positive results, samples were processed in duplicate 
and positive and negative controls, as well as milk without serum were 
added to each step of the reaction. A positive reaction was defined as 
absorbance equal to or greater than the cut-off value.
Cut-off setting
There were 19 negative sera of Cebus apella species used, provided 
by the Tufted Capuchin Monkey Procreation Center of the University of 
the State of São Paulo (UNESP), in Araçatuba, São Paulo, Brazil. Results 
were expressed as absorbance and, for higher specificity, the cut-off value 
was set by adding up three standard deviations to the arithmetic mean 
of serum absorbances7,11,16. 
RESULTS
1. Standardization of the enzymatic reaction for detection of IgG 
antibodies in monkey sera: The results of positive and negative control 
sera standardizations as well as titrations of anti-monkey IgG conjugate 
are shown in Tables 1 and 2. Tables 3 and 4 show the results of block 
titration of antigen and IAF.
Dilutions at 1:320, 1:40, and 1:3000 for antigen, serum and conjugate, 
respectively, showed the highest reactivity. 
For cut-off setting, mean absorbance of 19 negative sera was 0.060 
Table 1
Titration of anti-monkey (IgG) conjugates with monkey sera  
positive for yellow fever
Dilution of positive 
monkey serum 
Conjugate dilution*
1:1000 1:2000 1:3000
1:20 2.662 1.444 1.254
1:40 1.298 1.210 0.987
1:80 1.185 1.139 0.803
1:160 1.177 1.106 0.589
1:320 1.150 1.005 0.497
1:640 1.028 0.934 0.391
* Anti-monkey conjugate (IgG) Sigma A:2054 with peroxidase; ascitic fluid: 
1:200; antigen 1:320. Substrate: ABTS. Absorbance readings: 405 nm. Multiskan 
analyzer.
Table 2
Titration of anti-monkey conjugates (IgG) with monkey serum negative for 
yellow fever 
Dilution of negative 
monkey serum
Conjugate dilution*
1:1000 1:2000 1:3000
1:20 0.087 0.070 0.055
1:40 0.078 0.062 0.043
1:80 0.064 0.050 0.037
1:160 0.051 0.045 0.028
1:320 0.039 0.031 0.019
1:640 0.023 0.014 0.001
* Anti-monkey conjugate (IgG) Sigma A:2054 with peroxidase; ascitic fluid: 
1:200; antigen 1:320. Substrate: ABTS. Absorbance readings: 405 nm. Multiskan 
analyzer.
Table 3
Dilution standardization of anti-yellow fever ascitic fluid using positive monkey serum control at 1:40 dilution
Ascitic fluid dilution Antigen dilution
1:20 1:40 1:80 1:160 1:320 1:640
1:200 1.533 1.444 1.344 1.313 1.108 0.964
1:400 1.002 0.987 0.886 0.765 0.605 0.505
1:800 0.601 0.503 0.440 0.313 0.277 0.231
1:1600 0.235 0.189 0.156 0.127 0.099 0.075
Anti-monkey conjugate (IgG) Sigma A:2054 with peroxidase, concentration: 1:3,000. Substrate: ABTS. Absorbance readings: 405 nm. Multiskan analyzer.
Table 4
Dilution standardization of anti-yellow fever immune ascitic fluid using negative monkey serum control at 1:40 dilution 
Ascitic fluid dilution Antigen dilution
1:20 1:40 1:80 1:160 1:320 1:640
1:200 0.083 0.080 0.071 0.049 0.035 0.016
1:400 0.071 0.054 0.052 0.044 0.039 0.010
1:800 0.052 0.046 0.040 0.016 0.022 0.005
1:1600 0.037 0.035 0.022 0.008 0.002 0.001
Anti-Monkey (IgG) conjugate Sigma A:2054 with peroxidase, concentration: 1:3,000. Substrate: ABTS. Absorbance readings: 405 nm. Multiskan analyzer
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and the standard deviation (SD) was 0.030. The reactivity cut-off value 
(mean + 3 SD) was 0.150.
2. Detection of yellow fever antibodies in monkey sera: No IgG 
antibodies against yellow fever virus were detected in the 570 sera 
samples of Alouatta caraya monkeys assayed using the ELISA previously 
standardized for this purpose.
DISCUSSION
1. Standardization of immunoenzymatic assay (ELISA): 
Immunoenzymatic assays for arbovirus studies were introduced in Brazil 
in 1984 for the diagnosis of human Rocio virus infections in sera collected 
in 1975 and 1976 from patients with clinical encephalitis14,15 , and later 
for the diagnosis of yellow fever virus infection6,24,25. 
Among laboratory methods for detection of antibodies and viral 
antigens in humans and arthropod vectors, ELISA is remarkable as a fast 
and sensitive assay. This test performance is comparable to those assays 
traditionally used for detection of arboviruses, such as neutralization test 
(N), hemagglutination inhibition (HI), immunofluorescence (IF), and 
complement fixation (CF)10,19,21,26.
The results of the present study show that ELISA was a fast, effective 
and adequate assay for detecting IgG antibodies in monkeys. Besides, a 
marketed anti-Rhesus conjugate could be used because of its reactivity 
with the New World’s monkey sera, which made the detection process 
easier.
A second advantage of ELISA is that it enables to process and analyze 
a large number of samples, which is fundamental in epidemiological 
investigations. Thus, ELISA adjusted to studies for detection of IgG 
antibodies can be used as an alternative method by reference laboratories 
or primate research centers for epidemiological surveillance of yellow 
fever in animal reserves. 
2. Detection of yellow fever antibodies in monkey sera: In the 
present study, no IgG antibodies against yellow fever virus were detected 
in simian sera. The serological test results corroborate the epidemiology 
of sylvatic yellow fever in the studied area. Although the Brazilian 
Ministry of Health has considered this place as an area of transition for 
yellow fever, to date, no epizootic or yellow fever outbreaks were reported 
in humans within this area.
In addition, entomological studies conducted in this area did not show 
the presence of yellow fever vectors. Culicid insect investigations in the 
region of Presidente Epitácio in neighboring areas of Porto Primavera 
HEP detected very low frequency of mosquitoes of the genera Sabethes 
and none of the Haemagogus20.
Another entomological study aimed to describing vector species 
within the western and northwestern region of the state of São 
Paulo4. Collections were carried out in 39 localities in four different 
areas. The most abundant mosquito species were Haemagogus 
leucocelaenus and Aedes albopictus. Haemagogus leucocelaenus was 
the most abundant species in the municipalities of Santa Albertina and 
Ouroeste, where there were reported cases of sylvatic yellow fever 
in 2000. In Presidente Epitácio, where monkeys were captured for 
the present study, 16 mosquitoes of the genus Sabethes were found. 
However, there were no mosquitoes found of the genera Haemagogus 
or Aedes albopictus. 
Non-human primates can act, in some circumstances, as sentinel 
animals of certain sylvatic zoonotic cycles. These cycles can be identified 
when epizootics occur, such as those caused by arbovirus and especially 
yellow fever virus infection.
Although they are extremely susceptible to the yellow fever virus, 
monkeys of the genus Allouata have been investigated for disease 
surveillance13. Yellow fever virus was detected in an immunohistochemical 
assay conducted in an Alouatta fusca monkey found dead in Santo 
Antonio das Missões, in 2001, after the occurrence of an epizootic in the 
southern state of Rio Grande do Sul. The cause of the monkey’s death 
was confirmed as yellow fever virus infection22.
This finding elicited a reassessment of yellow fever status in Rio 
Grande do Sul. The state’s northwestern region, previously with no 
signs of disease occurrence, became an area of transition and the whole 
population of neighboring municipalities, as well as those traveling to 
these areas were vaccinated13.
Because of their susceptibility to yellow fever virus, these monkeys 
are good indicators of viral circulation. Their susceptibility has not been 
interpreted yet as a warning sign for the implementation of preventive 
actions, such as vaccination.
Based on the results in the present study, it is proposed the use of 
ELISA in animals less susceptible to yellow fever virus fatal infection, 
for instance Cebus apella species (tufted capuchin monkey), as an 
instrument for active search in the epidemiological surveillance of yellow 
fever, allowing the implementation of preventive actions even before the 
occurrence of epizootics.
RESUMO
Circulação de anticorpos contra o vírus amarílico em população 
simiana da região da usina hidrelétrica de Porto Primavera, São 
Paulo, Brasil
A febre amarela (FA) é doença infecciosa aguda de origem viral 
transmitida por mosquitos. No ciclo silvestre, o vírus é mantido por meio 
da infecção de macacos e da transmissão transovariana nos vetores. A 
vigilância sobre populações de primatas não humanos torna-se necessária 
para detectar a circulação viral, quando ainda está restrito a epizootias, e 
para determinar sua presença em regiões indenes ou de transição para a 
doença. Padronizou-se a técnica ELISA (Enzyme Linked Immunosorbent 
Assay) para determinar a prevalência de anticorpos da classe IgG 
contra o vírus da FA em soros de bugios (Alouatta caraya) da região do 
reservatório da Usina Hidrelétrica de Porto Primavera, SP. Foram testados 
soros de 570 macacos sendo que nenhuma amostra mostrou-se reativa 
para a presença de anticorpos contra o vírus da FA. Os resultados são 
coerentes com a epidemiologia da FA na região. Mesmo sendo área de 
transição, não se conhece, até o momento, ocorrência de epizootia ou 
surto de FA em humanos e investigações entomológicas não apontaram a 
presença de vetores para esta arbovirose. A técnica mostrou-se sensível, 
rápida e útil à vigilância epidemiológica como instrumento de busca 
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ativa permitindo desencadear ações preventivas, como vacinação, antes 
mesmo do surgimento de epizootias.
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